Dr. Tarik Messaoud is a physician, consultant, and speaker at pharmacovigilance conferences in the USA, Canada, Europe and In UEA. He holds a graduate diploma in Clinical Research and Clinical Trial Management from the University of Montreal, Canada. With 15 years of experience in pharmacovigilance, he specializes in oncology drug safety, particularly in immunotherapy and adoptive cell therapy involving checkpoint inhibitors. Dr. Messaoud has worked with prominent pharmaceutical companies in USA and Canada such as Merck/MSD and GlaxoSmithKline, as well as Iovance biotechnologist focused on patient safety. He possesses extensive knowledge of pharmacovigilance regulations from Health Canada, the FDA, ICH, and the European Medicines Agency. Currently, he leads pharmacovigilance training initiatives and mentors students at McGill University and Access Clinical Research while also developing eLearning courses in pharmacovigilance.